ACS & ASCO are Stronger Together: Cancer.Net content is now available on cancer.org.
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Published on: June 13, 2024
A recent study shows that giving immunotherapy before surgery for stage III melanoma can help stop the spread of the disease and cut time spent in treatment.
Published on: June 13, 2024
A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain.
Published on: June 13, 2024
A study has shown that giving patients with lung cancer a targeted therapy drug after combined chemotherapy and radiation therapy helps them live longer without the cancer growing or spreading.
Published on: June 1, 2023
Follow research highlighted each day in this ongoing meeting by checking out the ASCO News Highlights for People with Cancer blog.
Published on: August 17, 2020
According to a new study, death rates from non-small cell lung cancer have fallen sharply in recent years, mostly due to advances in treatment.
Published on: June 18, 2020
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
Published on: March 19, 2020
Medicare has changed its policies to make it easier for older Americans to “see” their doctors without going in for an office visit, using their home computer or other device.
Published on: February 27, 2020
Palliative care is not just for end of life. It helps anyone with a serious illness manage the symptoms and stress of their condition. Learn about pain relief, emotional support, and other types of palliative care.